296 related articles for article (PubMed ID: 26758945)
21. [Statins and asthma].
Pawlak J; Ziętkowski Z; Bodzenta-Łukaszyk A
Postepy Hig Med Dosw (Online); 2011 Mar; 65():177-89. PubMed ID: 21502694
[TBL] [Abstract][Full Text] [Related]
22. Are Statins out in the COLD? The STATCOPE Trial.
Mancini GB; Road J
Can J Cardiol; 2015 Aug; 31(8):970-3. PubMed ID: 26117620
[TBL] [Abstract][Full Text] [Related]
23. [Statins in COPD--theoretical reflections].
Hannink JD; Heijdra YF
Ned Tijdschr Geneeskd; 2010; 154():A2196. PubMed ID: 20977805
[TBL] [Abstract][Full Text] [Related]
24. Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan.
Ishida W; Kajiwara T; Ishii M; Fujiwara F; Taneichi H; Takebe N; Takahashi K; Kaneko Y; Segawa I; Inoue H; Satoh J
Tohoku J Exp Med; 2007 Jul; 212(3):265-73. PubMed ID: 17592214
[TBL] [Abstract][Full Text] [Related]
25. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study.
Blamoun AI; Batty GN; DeBari VA; Rashid AO; Sheikh M; Khan MA
Int J Clin Pract; 2008 Sep; 62(9):1373-8. PubMed ID: 18422598
[TBL] [Abstract][Full Text] [Related]
26. Effect of statins on total cholesterol concentrations, cardiovascular morbidity, and all-cause mortality in chronic obstructive pulmonary disease: a population-based cohort study.
Sheng X; Murphy MJ; MacDonald TM; Schembri S; Simpson W; Winter J; Winter JH; Wei L
Clin Ther; 2012 Feb; 34(2):374-84. PubMed ID: 22244052
[TBL] [Abstract][Full Text] [Related]
27. Statin use is associated with reduced mortality in COPD.
Søyseth V; Brekke PH; Smith P; Omland T
Eur Respir J; 2007 Feb; 29(2):279-83. PubMed ID: 17050558
[TBL] [Abstract][Full Text] [Related]
28. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease.
van Gestel YR; Hoeks SE; Sin DD; Simsek C; Welten GM; Schouten O; Stam H; Mertens FW; van Domburg RT; Poldermans D
Am J Cardiol; 2008 Jul; 102(2):192-6. PubMed ID: 18602520
[TBL] [Abstract][Full Text] [Related]
29. Statin use and risk of COPD exacerbation requiring hospitalization.
Wang MT; Lo YW; Tsai CL; Chang LC; Malone DC; Chu CL; Liou JT
Am J Med; 2013 Jul; 126(7):598-606.e2. PubMed ID: 23684060
[TBL] [Abstract][Full Text] [Related]
30. Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.
Frantzi N; Nguyen XP; Herr C; Alter P; Söhler S; Soriano D; Watz H; Waschki B; Trinkmann F; Eichenlaub M; Trudzinski FC; Michels-Zetsche JD; Omlor A; Seiler F; Moneke I; Biertz F; Rohde G; Stolz D; Welte T; Kauczor HU; Kahnert K; Jörres RA; Vogelmeier CF; Bals R; Fähndrich S;
Respir Res; 2024 May; 25(1):207. PubMed ID: 38750572
[TBL] [Abstract][Full Text] [Related]
31. Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality - The STATUETTE Cohort Study.
Damkjær M; Håkansson K; Kallemose T; Ulrik CS; Godtfredsen N
Int J Chron Obstruct Pulmon Dis; 2021; 16():579-589. PubMed ID: 33707941
[TBL] [Abstract][Full Text] [Related]
32. Do Statins Have Antidepressant Effects?
Köhler-Forsberg O; Gasse C; Berk M; Østergaard SD
CNS Drugs; 2017 May; 31(5):335-343. PubMed ID: 28303466
[TBL] [Abstract][Full Text] [Related]
33. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
[TBL] [Abstract][Full Text] [Related]
34. [Corticosteroid treatment in airways narrowing].
Chazan R
Pneumonol Alergol Pol; 2008; 76(2):96-100. PubMed ID: 18464224
[TBL] [Abstract][Full Text] [Related]
35. Simvastatin Therapy and Bronchoalveolar Lavage Fluid Biomarkers in Chronic Obstructive Pulmonary Disease.
Patyk I; Rybacki C; Kalicka A; Rzeszotarska A; Korsak J; Chciałowski A
Adv Exp Med Biol; 2019; 1150():43-52. PubMed ID: 30255302
[TBL] [Abstract][Full Text] [Related]
36. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence.
Young RP; Hopkins R; Eaton TE
Postgrad Med J; 2009 Aug; 85(1006):414-21. PubMed ID: 19633007
[TBL] [Abstract][Full Text] [Related]
37. Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?
McCarey DW; Sattar N; McInnes IB
Arthritis Res Ther; 2005; 7(2):55-61. PubMed ID: 15743490
[TBL] [Abstract][Full Text] [Related]
38. Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study.
Liu JC; Yang TY; Hsu YP; Hao WR; Kao PF; Sung LC; Chen CC; Wu SY
Oncotarget; 2016 Sep; 7(37):59618-59629. PubMed ID: 27517752
[TBL] [Abstract][Full Text] [Related]
39. The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational research.
Cao C; Wu Y; Xu Z; Lv D; Zhang C; Lai T; Li W; Shen H
Sci Rep; 2015 Nov; 5():16461. PubMed ID: 26553965
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
